Lundbeck Pharmaceuticals LLC
3 drugs in NADAC|0 Generic,3 Brand
Lundbeck Pharmaceuticals LLC lists 3 NDCs in the CMS NADAC file (0 generic, 3 brand), at an average NADAC of $34.07 per unit, with a week-over-week move of -0.1% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
3
0G / 3B
Avg Price / Unit
$34.0673
$12.47 – $59.82
Avg 7d Change
-0.11%
Across 2 drugs with changes
7d Activity
of 3 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
clobazam market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Benzodiazepine therapeutic class
Review the broader class where Lundbeck Pharmaceuticals LLC has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Lundbeck Pharmaceuticals LLC make?
Lundbeck Pharmaceuticals LLC lists 3 NDCs in the CMS NADAC file — 0 generic and 3 brand products.
What is the average price of Lundbeck Pharmaceuticals LLC drugs?
The average NADAC across Lundbeck Pharmaceuticals LLC's portfolio is $34.0673 per unit, ranging from $12.4731 to $59.8160.
What types of drugs does Lundbeck Pharmaceuticals LLC make?
Lundbeck Pharmaceuticals LLC makes drugs across 1 FDA pharmacologic class. The most common by NDC count are Benzodiazepine (3).
Has Lundbeck Pharmaceuticals LLC had any drug recalls?
No FDA enforcement recalls are matched to Lundbeck Pharmaceuticals LLC in the openFDA feed.
How has Lundbeck Pharmaceuticals LLC's pricing changed recently?
Over the past 7 days, 0 Lundbeck Pharmaceuticals LLC products rose and 2 fell, with a portfolio-wide average change of -0.1%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ONFI 20 MG TABLET clobazam | $59.8160 per EA | -0.18% |
ONFI 10 MG TABLET clobazam | $29.9129 per EA | 0.00% |
ONFI 2.5 MG/ML SUSPENSION clobazam | $12.4731 per ML | -0.03% |